One Year Later, Insurers Backpedal on Prior Authorization Promises, Leaving Patients and Doctors Frustrated

A year after dozens of health insurers signed a six-part pledge to streamline the prior authorization process and reduce obstacles to doctor-recommended care, a growing chorus of patients, advocates, and clinicians asserts that little has improved. In fact, some insurers are now signaling they will not fully implement the promised initiatives, raising concerns about the effectiveness of voluntary industry commitments in a system often criticized for prioritizing financial interests over patient well-being.

The pledge, announced in June of the previous year by the Trump administration, aimed to reform prior authorization, a contentious practice requiring pre-approval from insurers before patients can receive certain treatments, medications, or services. While the health insurance industry trade group, AHIP, claims a reduction of 6.5 million prior authorizations—an 11% decrease—since the pledge was made, critics remain unconvinced, labeling the commitment as “performative” and lacking any real enforcement mechanism.

The Frustration Mounts: Patients and Clinicians Speak Out

The sentiment on the ground is one of deep disappointment and frustration. U.S. Rep. Greg Murphy (R-N.C.), a physician and co-chair of the GOP Doctors Caucus, voiced his alarm, stating, “It has never been this bad for patients.” His sentiment is echoed by patient advocates who have direct experience with the arduous prior authorization process. Sally Nix, a patient advocate living with a chronic disease, described the voluntary pledge as having “no teeth,” suggesting it was more for show than substantive change.

The core issue remains the pervasive nature of prior authorization. While the insurance industry argues it’s a vital safeguard to control costs, prevent waste and fraud, and protect patients from unnecessary procedures, the reality for many is a significant barrier to timely and appropriate care. This bureaucratic hurdle can delay or even prevent access to everything from routine urgent care to life-saving cancer treatments, creating immense stress and potentially adverse health outcomes.

A History of Promises and Skepticism

The concept of prior authorization has been a fixture in healthcare for decades, evolving into a complex system that varies significantly between insurance providers. The insurance industry has consistently defended its necessity, with AHIP spokesperson Chris Bond emphasizing, “Prior authorization is a vital patient safeguard.”

However, the landscape shifted significantly in the wake of the 2024 killing of UnitedHealthcare CEO Brian Thompson. This tragic event ignited a national outcry against what many perceived as insurance companies prioritizing profits over patient care, leading to increased vocalization from both patients and physicians regarding their negative experiences with insurance denials and tactics.

Prior authorization reform has emerged as a rare area of bipartisan agreement in healthcare. In a significant development, the House Ways and Means Committee unanimously advanced a bill on July 15 that would mandate Medicare Advantage plans to disclose all services subject to prior authorization and report data on denials and grievances to the federal government. This legislative push underscores the widespread dissatisfaction with the status quo.

When the industry pledge was initially announced, Centers for Medicare & Medicaid Services (CMS) Administrator Mehmet Oz characterized it as a direct response to public anger, noting, "There’s violence in the streets over these issues." He expressed anticipation for tangible results, stating, “Americans are upset about it.”

Despite these pronouncements, skepticism persists. Mike Gartner, founder of Health Access Innovation, an organization dedicated to helping patients overcome insurance denials, doubts the sincerity of insurers’ policy changes. He contends that the 11% reduction in prior authorizations cited by AHIP “hides a lot of nuance.” Gartner points out that patients requiring the most expensive treatments, such as those for cancer, continue to face disproportionate denials.

AHIP clarified that their reported reduction figures pertain to medical services and do not include prescription medications. Crucially, the trade group has not provided detailed breakdowns of which services have been removed from prior authorization requirements or how these reductions vary among individual insurers.

Furthermore, promises made by the federal government regarding oversight have yet to materialize. Last year, CMS Administrator Oz indicated that the federal government would be “evaluating progress” and “driving accountability,” even foreshadowing “public dashboards.” However, no such dashboards have been created, and federal officials have been unresponsive to inquiries about their accountability measures for insurance companies.

Congressman Murphy remains resolute in his lack of faith in the industry’s self-governance. "I didn’t believe insurance companies then," he stated, "and I don’t believe them now."

"At War" With an Insurer: A Case Study in Navigating the System

The challenges faced by patients are starkly illustrated by the experience of Betsy Adler and Justin Young of Stillwater, Minnesota. Shortly after their daughter Coco was born with a serious heart defect in February, the family found themselves grappling with unexpected out-of-network charges from their new insurer, Medica. Medica was among the many insurers that initially signed the industry pledge.

Adler reported verifying with her employer’s human resources department and Medica’s website to ensure her maternal-fetal specialists and hospital were in-network before their new plan took effect. However, claims began to be processed as out-of-network, accumulating over $4,000 in charges on top of existing in-network bills within weeks.

When Adler, a psychotherapist, contacted Medica to understand the situation, she was informed that a referral from her primary care provider had not been submitted. Her attempts to rectify the issue proved futile. In one instance, Medica required her to visit a new clinic for a referral, only to later claim the referral was never received due to a malfunctioning fax machine.

“I have a critically ill child,” Adler recounted, reflecting on the immense stress of simultaneously caring for her infant and battling her insurer. “I can either spend my emotional energy at war with Medica, or I can let it go and just enjoy my time with my daughter.”

Medica spokesperson Greg Bury declined to comment on the specific case due to patient privacy regulations but stated in an email that the company is “committed to working with her to ensure she understands what is covered under her benefits and our responsibilities.”

One of the six commitments outlined in the industry pledge was to honor a 90-day grace period, often referred to as “continuity of care,” for patients switching insurance plans, effective January 1 of the current year. This provision is intended to allow patients to continue receiving authorized services and medications under their previous insurer. However, as Sabrina Corlette, a research professor at Georgetown University’s Center on Health Insurance Reforms, notes, the pledge’s wording is nuanced. Insurers are not necessarily obligated to honor another company’s network parameters. In the Adler and Young’s case, Medica was not compelled to cover out-of-network providers as if they were in-network, even if they had been under their previous plan. The family ultimately switched insurers again when Coco was one month old to mitigate further out-of-network costs.

Denial After Approval: The Illusion of Security

Sally Nix, the patient advocate, further highlights the deceptive nature of the prior authorization landscape. She argues that insurers are not including data on the “loopholes they create” in their statistics. A significant loophole is the ability for insurers to retroactively deny payment for preapproved care. Nix herself experienced this when her insurer processed, and then later denied, a claim for injections to manage her chronic nerve pain. “Patients are going to see a lot more retroactive denials,” she warned.

Jocelyn Austin, a 49-year-old resident of Amherst, New York, faced a similar predicament. After developing an addiction to sleeping and anxiety pills, she spent weeks at an inpatient treatment center for substance abuse. Her insurer, Independent Health, had initially approved the admission. Upon discharge, Austin had been substance-free for an extended period.

However, in December, the treatment facility billed her over $12,000, indicating her insurer had not paid for the approved treatment. This was in addition to a $10,000 deductible she had already paid. The approval letters from Independent Health contained a disclaimer stating, “authorization is not a guarantee of claim payment.”

Frank Sava, a spokesperson for Independent Health, explained that the denial was issued and upheld because the services rendered were “inconsistent with the care that was authorized” and “the medical record did not sufficiently support what was billed.” He added that these findings were confirmed by an external consultant.

Despite an explanation of benefits indicating the provider, not the patient, was responsible for the cost, the treatment facility continued to demand payment from Austin. She remains adamant that insurance companies “should be held accountable.”

"Significant Work Ahead": Technology and Transparency Concerns

Another key commitment in the insurers’ pledge involved adopting new technology to standardize the electronic submission of prior authorization requests. CMS Deputy Administrator Chris Klomp noted last year that over half of prior authorizations were still processed manually via phone or fax.

In April, AHIP announced an update regarding this technological initiative, stating that participating insurers would adopt new standards on a rolling basis, with full implementation expected by January 1, 2027. However, a significant number of insurers—eight in total—who initially signed the pledge did not endorse this technology update. These insurers include Alignment Health Plan, EmblemHealth, HealthFirst, Independent Health, Medica, MVP Health Care, Point32Health, and SummaCare, whose beneficiaries are spread across the nation.

While most of these insurers provided emailed statements affirming their commitment to prior authorization reform, they declined interviews. Alignment Health Plan cited concerns about the “transfer of confidential member health information through a non-standardized process involving third-party participation,” suggesting such extensive data sharing was not contemplated in the original commitment. Medica’s spokesperson stated that while they support standardization efforts, the April update presented “a significant technical and operational hurdle that we are not able to commit to at this time.” EmblemHealth indicated in late June that it would sign onto the commitment after being queried about its non-endorsement.

AHIP spokesperson Chris Bond expressed optimism that more plans would join in the coming months, asserting that health plans are “working continuously to implement their commitments to simplify and improve the experience.” He acknowledged, however, that “there is still significant work ahead.”

The pledge also included a commitment to enhance transparency and provide “clear, easy-to-understand explanations” to patients, a requirement already mandated by the Affordable Care Act. Yet, according to Gartner, insurance companies frequently fail to adequately explain claim denials, often providing “inconsistent and contradictory information.” Both Gartner and Congressman Murphy suspect that insurers are increasingly employing artificial intelligence to generate denials, hoping patients will abandon their appeals.

“They craft the pathways to basically deny things immediately with the hope that people will give up,” Murphy observed. He expressed a desire for former President Donald Trump to issue executive orders addressing these issues, lamenting, “The problem is the insurance industry is the strongest lobby in this town.”

The ongoing struggles of patients and the apparent reluctance of some insurers to fully embrace promised reforms highlight the persistent challenges in navigating the U.S. healthcare system and the critical need for more robust oversight and accountability mechanisms to ensure patient care is not unduly hindered by administrative processes.